Profil
Dr. Mark Philip is Chief Operating Officer at Portal Instruments, Inc.
Dr.Philip was previously employed as President by Stryker Biotech LLC, and President & Chief Executive Officer by Zycos, Inc. He also served on the board at Stryker Biotech LLC.
He received he undergraduate degree from Nottingham Trent University, an MBA from Lake Forest Graduate School of Management.
Anciens postes connus de Mark Philip
| Sociétés | Poste | Fin |
|---|---|---|
Znomics, Inc.
 Znomics, Inc. Financial ConglomeratesFinance Znomics, Inc. is a shell company, which is seeking and investigating potential assets, property or businesses to acquire and intend to commence operations in the future through the acquisition of a going concern. It was previously an exploration stage company that was set up to engage in the exploration of mineral properties. Znomics was founded on March 20, 2006 and is headquartered in Minneapolis, MN. | President | 23/10/2009 |
Zycos, Inc.
 Zycos, Inc. Pharmaceuticals: MajorHealth Technology Zycos Inc. used to develop and market anticancer pharmaceutical and medical therapies and products. The company used to focus on drug discovery before redirecting toward drug development. Its core technology used to provide a direct method for the treatment of chronic viral infections and cancer as well as single product that work on all autoimmune diseases. Zycos was founded in 1996 and located in Lexington, MA | President | 01/01/2004 |
Portal Instruments, Inc.
 Portal Instruments, Inc. Medical SpecialtiesHealth Technology Portal Instruments, Inc. operates as a medical device company that focuses on drug delivery systems. It manufactures jet injectors that deliver drugs through the skin without a needle at specific depths and volumes. The firm engages in developing and commercializing a needle-free platform technology to transform the delivery of medicines and improve the patient experience. The company was founded by Patrick A. Anquetil and Ian W. Hunter in 2012 and is headquartered in Cambridge, MA. | Directeur des opérations | - |
Stryker Biotech LLC
 Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA. | President | - |
Formation de Mark Philip
| Nottingham Trent University | Undergraduate Degree |
| Lake Forest Graduate School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Znomics, Inc.
Znomics, Inc. Financial ConglomeratesFinance Znomics, Inc. is a shell company, which is seeking and investigating potential assets, property or businesses to acquire and intend to commence operations in the future through the acquisition of a going concern. It was previously an exploration stage company that was set up to engage in the exploration of mineral properties. Znomics was founded on March 20, 2006 and is headquartered in Minneapolis, MN. | Finance |
Stryker Biotech LLC
Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA. | Health Technology |
Zycos, Inc.
Zycos, Inc. Pharmaceuticals: MajorHealth Technology Zycos Inc. used to develop and market anticancer pharmaceutical and medical therapies and products. The company used to focus on drug discovery before redirecting toward drug development. Its core technology used to provide a direct method for the treatment of chronic viral infections and cancer as well as single product that work on all autoimmune diseases. Zycos was founded in 1996 and located in Lexington, MA | Health Technology |
Portal Instruments, Inc.
Portal Instruments, Inc. Medical SpecialtiesHealth Technology Portal Instruments, Inc. operates as a medical device company that focuses on drug delivery systems. It manufactures jet injectors that deliver drugs through the skin without a needle at specific depths and volumes. The firm engages in developing and commercializing a needle-free platform technology to transform the delivery of medicines and improve the patient experience. The company was founded by Patrick A. Anquetil and Ian W. Hunter in 2012 and is headquartered in Cambridge, MA. | Health Technology |